Attached files

file filename
EX-99.1 - EX-99.1 - PROTALEX INCv399052_ex99-1.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

 

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): January 20, 2015

 

PROTALEX, INC.

(Exact Name of Registrant as Specified in Charter)

 

DELAWARE   000-28385   91-2003490
(State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.)

 

131 Columbia Turnpike, Suite 1

Florham Park, NJ 07932

  07932
(Address of Principal Executive Offices)   (Zip Code)

 

(215) 862-9720

(Registrant’s telephone number, including area code)

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act of 1933, as amended (17 CFR 230.425)
   
o Soliciting material pursuant to Rule 14a-12 under the Securities Exchange Act of 1934, as amended (17 CFR 240.14a-12)
   
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.14d-2(b))
   
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13e-4(c))

 

 

 
 

 

Item 8.01.        Other Events.

 

Protalex, Inc. has updated its investor presentation. A copy of the investor presentation is attached as Exhibit 99.1 hereto.

 

Item 9.01.        Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit

No.

 

Description

99.1 Investor Presentation as of January 20, 2015.
   

 

*      *      *      *      *      *

 

-2-
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  

  PROTALEX, INC.  
       
Dated: January 20, 2015 By: /s/ Arnold P. Kling  
    Arnold P. Kling  
    President  
       

 

 

 

 

 

-3-